Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)

NCT02959762 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Insulin Resistance
Obesity in Diabetes
Nutritional and Metabolic Diseases
Hyperlipidemia
Hyperglycemia
Cardiovascular Diseases

Interventions

DIETARY_SUPPLEMENT: Placebo-Control
DIETARY_SUPPLEMENT: Low-Dose Vitamin K2 (menaquinone-7; 45-mcg/d)
DIETARY_SUPPLEMENT: High-Dose Vitamin K2 (menaquinone-7; 90 mcg/d)

Sponsor

Augusta University